Dexmedetomidine Hydrochloride Injection
NDC Package 71225-126-06
Package Information
Dexmedetomidine Hydrochloride injection is classified as a
administered via intravenous route. This formulation utilizes a injection delivery system. Marketed by Slayback Pharma Llc, this product is identified by NDC 71225-126 and is authorized under FDA application ANDA212791.Identification & Billing
- RxCUI: 1718900 - dexmedeTOMIDine HCl 80 MCG in 20 ML Injection
- RxCUI: 1718900 - 20 ML dexmedetomidine 0.004 MG/ML Injection
- RxCUI: 1718900 - dexmedetomidine (as dexmedetomidine HCl) 80 MCG per 20 ML Injection
- RxCUI: 1718906 - dexmedeTOMIDine HCl 200 MCG in 50 ML Injection
- RxCUI: 1718906 - 50 ML dexmedetomidine 0.004 MG/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71225 - Slayback Pharma Llc
- 71225-126 - Dexmedetomidine Hydrochloride
- 71225-126-06 - 10 BOTTLE in 1 CARTON / 100 mL in 1 BOTTLE (71225-126-03)
- 71225-126 - Dexmedetomidine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71225-126). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71225-126-06 identifies a specific commercial package of 10 bottle in 1 carton / 100 ml in 1 bottle (71225-126-03) of Dexmedetomidine Hydrochloride, a human prescription drug labeled by Slayback Pharma Llc. This injection is formulated for intravenous use and contains dexmedetomidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Slayback Pharma Llc on December 06, 2019.
How is this Slayback Pharma Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71225012606. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.